GSA Capital Partners’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-24,634
| Closed | -$702K | – | 1795 |
|
|
2024
Q3 | $702K | Buy |
24,634
+9,810
| +66% | +$280K | 0.05% | 686 |
|
|
2024
Q2 | $391K | Buy |
+14,824
| New | +$391K | 0.03% | 1122 |
|
|
2024
Q1 | – | Sell |
-8,760
| Closed | -$369K | – | 1788 |
|
|
2023
Q4 | $369K | Buy |
+8,760
| New | +$369K | 0.03% | 1000 |
|
|
2023
Q3 | – | Sell |
-32,736
| Closed | -$621K | – | 1687 |
|
|
2023
Q2 | $621K | Buy |
+32,736
| New | +$621K | 0.06% | 606 |
|
|
2022
Q4 | – | Sell |
-95,146
| Closed | -$531K | – | 1655 |
|
|
2022
Q3 | $531K | Buy |
95,146
+55,329
| +139% | +$309K | 0.07% | 523 |
|
|
2022
Q2 | $155K | Buy |
+39,817
| New | +$155K | 0.02% | 1132 |
|
|
2022
Q1 | – | Sell |
-40,654
| Closed | -$346K | – | 1597 |
|
|
2021
Q4 | $346K | Sell |
40,654
-40,516
| -50% | -$345K | 0.04% | 845 |
|
|
2021
Q3 | $705K | Buy |
+81,170
| New | +$705K | 0.07% | 494 |
|
|
2021
Q1 | – | Sell |
-5,175
| Closed | -$239K | – | 1280 |
|
|
2020
Q4 | $239K | Buy |
+5,175
| New | +$239K | 0.04% | 877 |
|